Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease

Cited by (374)

Items 101–200 of 374

1. Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid
   Yijun Pan, Jennifer Lynn Short, Stephanie A. Newman, Kwok Ho Christopher Choy, Durgesh Tiwari, Christopher Yap, Danielle Senyschyn, William A. Banks, Joseph A. Nicolazzo · 2018 · Brain Behavior and Immunity
2. The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
   Péter Illés, Patrizia Rubini, Lumei Huang, Yong Tang · 2019 · Expert Opinion on Therapeutic Targets
3. Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative Stress
   Kazuki Yokokawa, Naotoshi Iwahara, Shin Hisahara, Miho C. Emoto, Taro Saito, Hiromi Suzuki, Tatsuo Manabe, Akihiro Matsumura, Takashi Matsushita, Syuuichirou Suzuki et al. · 2019 · Journal of Alzheimer s Disease
4. Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease
   Priyanka Madhu, Samrat Mukhopadhyay · 2021 · Journal of Cellular Biochemistry
5. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease
   Jarrah O.-Z.J. Kron, Ryan J. Keenan, Daniël Hoyer, Laura H. Jacobson · 2023 · The Annual Review of Pharmacology and Toxicology
6. Polyphenols Derived from Lychee Seed Suppress Aβ (1-42)-Induced Neuroinflammation
   Yong Tang, Rui Xiong, Anguo Wu, Chong‐Lin Yu, Ya Zhao, Wenqiao Qiu, Xiuling Wang, Jin‐Feng Teng, Jian Liu, Hạixia Chen et al. · 2018 · International Journal of Molecular Sciences
7. From beta amyloid to altered proteostasis in Alzheimer’s disease
   Amalia Cecilia Bruni, Livia Bernardi, Carlo Gabelli · 2020 · Ageing Research Reviews
8. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease
   Rosen, Rebecca F., Tomidokoro, Yasushi, Farberg, Aaron S., Dooyema, Jeromy, Ciliax, Brian, Preuss, Todd M., Neubert, Thomas A., Ghiso, Jorge A., LeVine, Harry, Walker, Lary C. · 2016 · Neurobiology of Aging
9. Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease
   Gilbert M. Rishton, Gary C. Look, Zhi‐Jie Ni, Jason Y. Zhang, Yingcai Wang, Yaodong Huang, Xiaodong Wu, Nicholas J. Izzo, Kelsie Mozzoni, Colleen S. Limegrover et al. · 2021 · ACS Medicinal Chemistry Letters
10. Alzheimer’s disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis
    Raz Dvir-Szternfeld, Giulia Castellani, Michal Arad, Liora Cahalon, Sarah Phoebeluc Colaiuta, Hadas Keren‐Shaul, Tommaso Croese, Chiara Burgaletto, Kuti Baruch, Tyler Kent Ulland et al. · 2021 · Nature Aging
11. Focused ultrasound as a novel strategy for Alzheimer disease therapeutics
    Ying Meng, Matthew Volpini, Sandra E. Black, Andrés M. Lozano, Kullervo Hynynen, Nir Lipsman · 2017 · Annals of Neurology
12. Molecular rotors report on changes in live cell plasma membrane microviscosity upon interaction with beta-amyloid aggregates
    Markéta Kubánková, Ismael López‐Duarte, Darya V. Kiryushko, Marina K. Kuimova · 2018 · Soft Matter
13. Importance of Hydrogen Bonding: Structure–Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer’s Disease Therapy
    Brendan J. Wall, Mark F. Will, Gideon K. Yawson, Paige J. Bothwell, David C. Platt, C. Fiore Apuzzo, Marjorie A. Jones, Gregory M. Ferrence, Michael I. Webb · 2021 · Journal of Medicinal Chemistry
14. Sinomenine inhibits amyloid beta-induced astrocyte activation and protects neurons against indirect toxicity
    Deepali Singh, Apurva Agrawal, Chitra Mohinder Singh Singal, Hriday Shanker Pandey, Pankaj Seth, Shiv Kumar Sharma · 2020 · Molecular Brain
15. Fucosterol inhibits the cholinesterase activities and reduces the release of pro-inflammatory mediators in lipopolysaccharide and amyloid-induced microglial cells
    Chun Hoong Wong, Sook Yee Gan, Swee Ching Tan, Siti Aisya Gany, Tiong Ying, Alexander Irvine Gray, John Ogbaji Igoli, Elaine Wan Ling Chan, Siew Moi Phang · 2018 · Journal of Applied Phycology
16. Amyloid β oligomers inhibit growth of human cancer cells
    Božena Pavliukevičienė, Aistė Zentelytė, Marija Jankunec, Giedrė Valiulienė, Martynas Talaikis, Rūta Navakauskienė, Gediminas Niaura, Gintaras Valinčius · 2019 · PLoS ONE
17. Signaling via the p75 neurotrophin receptor facilitates amyloid-β-induced dendritic spine pathology
    Patnaik, Abhisarika, Zagrebelsky, Marta, Korte, Martin, Holz, Andreas · 2020 · Scientific Reports
18. Advances in Proteasome Enhancement by Small Molecules
    Dare E. George, Jetze J. Tepe · 2021 · Biomolecules
19. Olfactory bulbectomy in mice triggers transient and long-lasting behavioral impairments and biochemical hippocampal disturbances
    Roberto Farina Almeida, Marcelo Ganzella, Daniele G. Machado, Samanta Oliveira Loureiro, Douglas Teixeira Leffa, André Quincozes‐Santos, Letícia Ferreira Pettenuzzo, Marta Maria Medeiros Frescura Duarte, Thiago Duarte, Diogo Onofre Souza · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
20. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease
    Yangfei Ji, Dan Wang, Boai Zhang, Hong Lu · 2019 · Journal of Integrative Neuroscience
21. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model
    María Clara Sellés, Juliana T.S. Fortuna, Maria F. Zappa-Villar, Yasmin P.R. de Faria, Amanda Santos de Souza, Cláudia Kimie Suemoto, Renata Elaine Paraízo Leite, Roberta Diehl Rodriguez, Lea T. Grinberg, Paula Cecilia Reggiani et al. · 2019 · Molecular Neurobiology
22. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells
    Jia-Mou Ren, Shu-Li Zhang, Xiaoling Wang, Zhi‐Zhong Guan, Xiaolan Qi · 2020 · Molecular Medicine Reports
23. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
    Saghar Rabiei Poor, Miren Ettcheto, Amanda C. Cano, Elena Sánchez‐López, Patrícia Regina Manzine, Jordi Olloquequi, Antoni Camins, Mohammad Javan · 2021 · Pharmaceuticals
24. Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease
    Shalini Mani, Rajni Dubey, I‐Chun Lai, Marianesan Arockia Babu, Sakshi Tyagi, Geeta Swargiary, Deepansh Mody, Manisha Singh, Shriya Agarwal, Danish Iqbal et al. · 2023 · Journal of Alzheimer s Disease
25. Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau
    Henry B. C. Taylor, Nigel J. Emptage, Alexander F. Jeans · 2021 · Cell Reports
26. Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model
    Noralyn Basco Manucat-Tan, Lin-lin Shen, Larisa Bobrovskaya, Mohammed Al‐Hawwas, Fiona H. Zhou, Yan‐Jiang Wang, Xin‐Fu Zhou · 2019 · Aging
27. Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease
    Janine Kutzsche, Sarah Schemmert, Markus Tusche, Joerg Neddens, Roland Rabl, Dagmar Jürgens, Oleksandr Brener, Antje Willuweit, Birgit Hutter‐Paier, Dieter Willbold · 2017 · Molecules
28. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.
    Paumier, Jean-Michel, Py, Nathalie A., García-González, Laura, Bernard, Anne, Stephan, Delphine, Louis, Laurence, Checler, Frédéric, Khrestchatisky, Michel, Baranger, Kévin, Rivera, Santiago · 2019 · The FASEB Journal
29. A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
    Fadi Rofo, Silvio R. Meier, Nicole G. Metzendorf, Jamie Ian Morrison, Alex Petrovic, Stina Syvänen, Dag Sehlin, Greta Hultqvist · 2022 · Neurotherapeutics
30. Exploring amyloid oligomers with peptide model systems
    Tuan D. Samdin, Adam G. Kreutzer, James S. Nowick · 2021 · Current Opinion in Chemical Biology
31. Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases
    Célia Seillier, Flavie Lesept, Olivier Toutirais, Fanny Potzeha, Manuel Blanc, Denis Vivien · 2022 · International Journal of Molecular Sciences
32. Liver X Receptor Activation with an Intranasal Polymer Therapeutic Prevents Cognitive Decline without Altering Lipid Levels
    María Eugenia Navas Guimaraes, Roi Lopez-Blanco, Juan Correa, Marcos Fernandez‐Villamarin, María Beatriz Bistué Millón, Pamela V. Martino Adami, Laura Morelli, Vijay Kumar, Michael F. Wempe, A. Claudio Cuello et al. · 2021 · ACS Nano
33. A Novel Selective PKR Inhibitor Restores Cognitive Deficits and Neurodegeneration in Alzheimer Disease Experimental Models
    Mati Lopez‐Grancha, Patrick Bernardelli, Nicolas Moindrot, Elisabeth Genet, Carine Vincent, Valérie Roudières, Alain Krick, Jean-François Sabuco, David Machnik, Delphine Ibghi et al. · 2021 · Journal of Pharmacology and Experimental Therapeutics
34. Physiological and pathological effects of amyloid-β species in neural stem cell biology
    Isabel Liste, Adela Bernabeu-Zornoza, Raquel Coronel, Charlotte Palmer, María Monteagudo, Alberto Zambrano · 2019 · Neural Regeneration Research
35. Isoflurane anesthesia promotes cognitive impairment by inducing expression of β-amyloid protein-related factors in the hippocampus of aged rats
    Shuai Zhang, Xueyuan Hu, Wei Guan, Luan Li, Bei Li, Qichao Tang, Honggang Fan · 2017 · PLoS ONE
36. The plasminogen activating system in the pathogenesis of Alzheimer’s disease
    Manuel Yepes · 2021 · Neural Regeneration Research
37. Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice
    Felipe Campos Ribeiro, Danielle Cozachenco, Luana Heimfarth, Juliana T.S. Fortuna, Guilherme B. de Freitas, Jorge M. de Sousa, Soniza Vieira Alves‐Leon, Renata Elaine Paraízo Leite, Cláudia Kimie Suemoto, Lea T. Grinberg et al. · 2023 · Communications Biology
38. Ion channel regulation by β-secretase BACE1 – enzymatic and non-enzymatic effects beyond Alzheimer's disease
    Sandra Lehnert, Stephanie Hartmann, Sabine Hessler, Helmuth Adelsberger, Tobias Huth, Christian Alzheimer · 2016 · Channels
39. Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
    Takeda, Keisuke, Uda, Aoi, Mitsubori, Mikihiro, Nagashima, Shun, Iwasaki, Hiroko, Ito, Naoki, Shiiba, Isshin, Ishido, Satoshi, Matsuoka, Masaaki, Inatome, Ryoko et al. · 2021 · Communications Biology
40. The link between periodontitis and Alzheimer's disease – emerging clinical evidence
    David T. S. Wu, Ye Won Cho, Matthew D. Spalti, Mark Bishara, Thomas Thong H. Nguyen · 2022 · Dentistry Review
41. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.
    Mak Adam Daulatzai · 2016 · Europe PMC (PubMed Central)
42. Depichering the Effects of Astragaloside IV on AD‐Like Phenotypes: A Systematic and Experimental Investigation
    Xuncui Wang, Feng Gao, Wen Xu, Yin Cao, Jinghui Wang, Guoqi Zhu · 2021 · Oxidative Medicine and Cellular Longevity
43. The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease
    Annibale Antonioni, Alessandro Martorana, Emiliano Santarnecchi, Harald Juergen Hampel, Giacomo Koch · 2025 · Alzheimer s & Dementia
44. Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome
    Gabriele Sansevero, Tatjana Begenisic, Marco Mainardi, Alessandro Sale · 2016 · Experimental Neurology
45. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease
    Lei Yu, Vladislav Petyuk, Shinya Tasaki, Patricia A. Boyle, Chris Gaiteri, Julie A. Schneider, Philip L. De Jager, David Alan Bennett · 2019 · JAMA Neurology
46. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice
    Kapadia, Minesh, Mian, M. Firoz, Michalski, Bernadeta, Azam, Amber B., Ma, Donglai, Salwierz, Patrick, Christopher, Adam, Rosa, Elyse, Zovkic, Iva B., Forsythe, Paul et al. · 2018 · Journal of Alzheimer's Disease
47. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.
    Mak Adam Daulatzai · 2016 · Europe PMC (PubMed Central) · Retracted
48. Albumin Exchange in Alzheimer's Disease: Might CSF Be an Alternative Route to Plasma?
    Manuel Menéndez‐González, Charles Gasparovic · 2019 · Frontiers in Neurology
49. Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease
    Manoj Govindarajulu, Sindhu Ramesh, Logan T. Neel, Mary Fabbrini, Manal Ali Buabeid, Ayaka Fujihashi, Darby Dwyer, Tyler O. Lynd, Karishma Shah, Kochupurackal P. Mohanakumar et al. · 2021 · Neurochemistry International
50. The Role of Synaptic Dysfunction in Alzheimer’s Disease
    Yixuan Amy Pei, Julie Davies, Melanie Zhang, Han‐Ting Zhang · 2020 · Journal of Alzheimer s Disease
51. Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin‐Based Derivatives
    Serena Montanari, Manuela Bartolini, Paolo Neviani, Federica Belluti, Silvia Gobbi, Letizia Pruccoli, Andrea Tarozzi, Federico Falchi, Vincenza Andrisano, Przemysław Miszta et al. · 2015 · ChemMedChem
52. Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice
    Wei Zhang, Guo Junhong, Xiaoyuan Niu, Wang Jie, Wang Zhaojun, Wu Meina, Wei Yang, Jun Zhang, Jin‐Shun Qi · 2017 · BioMed Research International
53. Real-Time Analysis of Binding Events between Different Aβ1–42 Species and Human Lilrb2 by Dual Polarization Interferometry
    Hu, Tao, Wang, Shuang, Chen, Chuanxia, Sun, Jian, Yang, Xiurong · 2017 · Analytical Chemistry
54. Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective
    Naomi Scarano, Francesca Musumeci, Beatrice Casini, Chiara Brullo, Pasqualina D’Ursi, Paola Fossa, Silvia Schenone, Elena Cichero · 2025 · International Journal of Molecular Sciences
55. The Alzheimer's disease amyloid-β peptide affects the size-dynamics of raft-mimicking Lo domains in GM1-containing lipid bilayers
    Galya Staneva, Nicolas Puff, Stanislav S. Stanimirov, Todor Tochev, Miglena I. Angelova, Michel Seigneuret · 2018 · Soft Matter
56. Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer’s and Lewy Body Diseases
    Mychael V. Lourenco, Felipe Campos Ribeiro, Luís E. Santos, Danielle Beckman, Helen M. Melo, Felipe Kenji Sudo, Cláudia Drummond, Naima Assunção, Bart Vanderborght, Fernanda Freire Tovar-Moll et al. · 2021 · Journal of Alzheimer s Disease
57. Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
    Panchanan Maiti, Jayeeta Manna, Joshua Thammathong, Bobbi Evans, Kshatresh Dutta Dubey, Souvik Banerjee, Gary Leo Dunbar · 2021 · Antioxidants
58. Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA2 balance
    Mélanie H. Thomas, Cédric Paris, Mylène Magnien, Julie Colin, Sandra Pelleïeux, Florence Coste, Marie‐Christine Escanyé, Thierry Pillot, J L Olivier · 2017 · Alzheimer s Research & Therapy
59. Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors
    Yung‐Chih Kuo, Rajendiran Rajesh · 2019 · Expert Review of Neurotherapeutics
60. Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod
    Henryk M. Jęśko, Iga Wieczorek, Przemysław Leonard Wencel, Magdalena Gąssowska-Dobrowolska, Walter J. Lukiw, Robert Piotr Strosznajder · 2021 · Frontiers in Molecular Neuroscience
61. Ellagic Acid Modulates the Amyloid Precursor Protein Gene via Superoxide Dismutase Regulation in the Entorhinal Cortex in an Experimental Alzheimer’s Model
    Wafaa S. Ramadan, Saleh Alkarim · 2021 · Cells
62. Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease
    Eva Rahman Kabir, Namara Mariam Chowdhury, Hasina Yasmin, Md. Tanvir Kabir, Rokeya Akter, Asma Perveen, Ghulam Md Ashraf, Shamima Akter, Md. Habibur Rahman, Sherouk Hussein Sweilam · 2022 · Current Neuropharmacology
63. A Systematic Review of the Effects of Capsaicin on Alzheimer’s Disease
    Deborah Inyang, Tasneem Saumtally, Chinelo Nonyerem Nnadi, Sharmila Devi, Po‐Wah So · 2023 · International Journal of Molecular Sciences
64. Amyloid-lowering monoclonal antibodies for the treatment of early Alzheimer’s disease
    Leisher, Solana, Bohorquez, Adriana, Gay, Marcus, Garcia, Victoria, Jones, Renarda, Baldaranov, Dobri, Rafii, Michael S. · 2023 · CNS Drugs
65. Aducanumab in Alzheimer’s Disease: A Critical Update
    Sumel Ashique, Ekta Sirohi, Shubneesh Kumar, Mohd Rihan, Neeraj Mishra, Shvetank Bhatt, Rupesh Kumar Gautam, Sachin Kumar Singh, Gaurav Gupta, Dinesh Kumar Chellappan et al. · 2023 · Current Medicinal Chemistry
66. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice
    Dongsheng Zhou, Huaxia Liu, Chenli Li, Fangyan Wang, Yaosheng Shi, Lingjiang Liu, Xin Zhao, Aiming Liu, Junfang Zhang, Chuang Wang et al. · 2016 · Metabolic Brain Disease
67. Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
    Anders Sandberg, Ernesto Berenjeno‐Correa, Rosa Crespo Rodriguez, Michael Axenhus, Sophia Schedin Weiss, Kevin Llewelyn Batenburg, Jeroen J.M. Hoozemans, Lars O. Tjernberg, Wiep Scheper · 2022 · Alzheimer s Research & Therapy
68. Polymorphism of fibrillar structures depending on the size of assembled Aβ17-42 peptides
    Mookyung Cheon, Mooseok Kang, Iksoo Chang · 2016 · Scientific Reports
69. βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer’s Disease
    Mickaël Audrain, Benoît Souchet, Sandro Alves, Romain Roger Fol, Arthur Viodé, Alexis Haddjeri-Hopkins, Satoru Tada, Nicola Salvatore Orefice, Charlène Joséphine, Alexis‐Pierre Bemelmans et al. · 2017 · Cerebral Cortex
70. Human brain organoids containing microglia that have arisen innately adapt to a β-amyloid challenge better than those in which microglia are integrated by co-culture
    Tyler J. Wenzel, Joseph D. Desjarlais, Darrell D. Mousseau · 2024 · Stem Cell Research & Therapy
71. Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
    Han‐Wen Chang, Ho-I. Ma, Yishan Wu, Ming‐Che Lee, Eric Chung‐Yueh Yuan, Shing‐Jong Huang, Yu-Sheng Cheng, Meng‐Hsin Wu, Ling‐Hsien Tu, Jerry C. C. Chan · 2022 · Chemical Science
72. Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer’s Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin
    Marta Domínguez-Prieto, Ana Luisa Velasco, Lourdes Vega, Arantxa Tabernero, José M. Medina · 2016 · Journal of Alzheimer s Disease
73. Physical & mental activities enhance the neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats
    Azza A. Ali, Dina Moustafa Abo El-Ella, Soad Z. El‐Emam, Amal Said Shahat, Rehab M. El‐Sayed · 2019 · Life Sciences
74. Treatment with Bifidobacteria can suppress Aβ accumulation and neuroinflammation in APP/PS1 mice
    Qiong Wu, Qifa Li, Xuan Zhang, Michael Ntim, Xuefei Wu, Ming Li, Li Wang, Jie Zhao, Shao Li · 2020 · PeerJ
75. Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease
    Li, Zhengyu, Gan, Li, Yan, Si, Yan, Yufang, Huang, Wei · 2020 · Translational Neuroscience · Retracted
76. Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer’s and Parkinson’s disease
    Maud M. A. Bouwman, Irene Frigerio, Chen‐Pei Lin, Niels Reijner, Wilma D. J. van de Berg, Laura E. Jonkman · 2025 · Alzheimer s Research & Therapy
77. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer’s Disease
    Norimichi Nakamura, Yasumasa Ohyagi, Tomohiro Imamura, Yuki T. Yanagihara, Kyoko Iinuma, Naoko Soejima, Hiroyuki Murai, Ryo Yamasaki, Jun‐ichi Kira · 2017 · Journal of Alzheimer s Disease
78. Therapeutic Strategies for Alzheimer’s Disease in the View of Diabetes Mellitus
    Yasumasa Ohyagi, Katsue Miyoshi, Norimichi Nakamura · 2019 · Advances in experimental medicine and biology
79. Mechanistic insights into procyanidins as therapies for Alzheimer's disease: A review
    Wenli Ruan, Shuo-Heng Shen, Yang Xu, Na Ran, Heng Zhang · 2021 · Journal of Functional Foods
80. The on-fibrillation-pathway membrane content leakage and off-fibrillation-pathway lipid mixing induced by 40-residue β-amyloid peptides in biologically relevant model liposomes
    Qinghui Cheng, Zhiwen Hu, Katelynne E. Doherty, Yuto J. Tobin-Miyaji, Wei Qiang · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
81. Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation
    Valencia-Olvera, Ana C., Balu, Deebika, Faulk, Naomi, Amiridis, Aspasia, Wang, Yueting, Pham, Christine, Avila-Munoz, Eva, York, Jason M., Thatcher, Gregory R.J., LaDu, Mary Jo · 2023 · Neurotherapeutics
82. Adiponectin: a potential target for obesity-associated Alzheimer’s disease
    Nikita Patil Samant, Girdhari Lal Gupta · 2021 · Metabolic Brain Disease
83. Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
    Iman I. Salama, Samia M. Sami, Ghada A. Elshaarawy, Amira Mohsen, Hanaa Attia, Solaf Ahmed Kamel, Mona Hamed Ibrahim, Mona Mostafa, Walaa A. Fouad, Hala M. Raslan · 2020 · PLoS ONE
84. Ginsenoside Rg1 improved learning and memory ability and reduces neuronal apoptosis in epileptic rats through ERK/CREB/BDNF signal pathway
    Jiawei Zhang, Chaochao Zhu, Yun Jin, Wangzhen Shen, Yunfeng Pan, Yan Shen · 2023 · Biochemical and Biophysical Research Communications
85. Platelet-driven formation of interface peptide nano-network biosensor enabling a non-invasive means for early detection of Alzheimer's disease
    Kai Zhang, Qianlu Yang, Zhenqiang Fan, Jianfeng Zhao, Hao Li · 2019 · Biosensors and Bioelectronics
86. Do Microglia default on network maintenance in Alzheimer's disease?
    Southam, Katherine A., Vincent, Adele J., Small, David H. · 2016 · Journal of Alzheimer s Disease
87. Understanding the Role of miR-33 in Brain Lipid Metabolism: Implications for Alzheimer's Disease
    Jaouen, Florence, Gascon, Eduardo · 2016 · The Journal of Neuroscience
88. Tau Spread, Apolipoprotein E, Inflammation, and More
    Bianca L. Gonzalez, Edsel M. Abud, Abigail M. Abud, Wayne W. Poon, Karen H. Gylys · 2017 · Neurologic Clinics
89. Neuroprotective effect of melatonin on soluble Aβ1–42-induced cortical neurodegeneration via Reelin–Dab1 signaling pathway
    Chunli Hu, Pan Wang, Shuman Zhang, Lili Ren, Yiheng Lv, Rui Ming Yin, Jing Bi · 2017 · Neurological Research
90. Psychobiotic Properties of Lactiplantibacillus plantarum in Neurodegenerative Diseases
    Mariagiovanna Di Chiano, Fabio Sallustio, Daniela Fiocco, Maria Teresa Rocchetti, Giuseppe Spano, Paola Pontrelli, Antonio Moschetta, Loreto Gesualdo, Raffaella Maria Gadaleta, Anna Gallone · 2024 · International Journal of Molecular Sciences
91. Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex
    Xin Yi Choo, Lachlan E. McInnes, Alexandra Grubman, Joanna Marta Wasielewska, Irina Belaya, Emma L. Burrows, Hazel Quek, Jorge Cañas-Martín, Sanna H. Loppi, Annika Sorvari et al. · 2022 · International Journal of Molecular Sciences
92. Cortical Astrocytes Acutely Exposed to the Monomethylarsonous Acid (MMAIII) Show Increased Pro-inflammatory Cytokines Gene Expression that is Consistent with APP and BACE-1: Over-expression
    Claudia Escudero‐Lourdes, Edith Elena Uresti‐Rivera, C. Oliva-González, Mónica Torres-Ramos, Patricia Aguirre-Bañuelos, A. Jay Gandolfi · 2016 · Neurochemical Research
93. Cellular levels of growth factor receptor bound protein 2 (Grb2) and cytoskeleton stability are correlated in a neurodegenerative scenario
    Piyali Majumder, Kasturi Roy, Brijesh Kumar Singh, Nihar Ranjan Jana, Debashis Mukhopadhyay · 2017 · Disease Models & Mechanisms
94. Characterization of a 3xTg‐AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background
    Jessica Virgili, Meryem Lebbadi, Cyntia Tremblay, Isabelle St‐Amour, Caroline Pierrisnard, Audrey Faucher-Genest, Vincent Émond, Carl Julien, Frédéric Calon · 2018 · Synapse
95. Age-dependent Disturbances of Neuronal and Glial Protein Expression Profiles in Areas of Secondary Neurodegeneration Post-stroke
    Murielle G. Kluge, Kim Jones, Lin Kooi Ong, Emma K. Gowing, Michael Nilsson, Andrew N. Clarkson, Frederick Rohan Walker · 2018 · Neuroscience
96. Synaptic Injury in the Thalamus Accompanies White Matter Injury in Hypoxia/Ischemia-Mediated Brain Injury in Neonatal Rats
    Na Liu, Xin Tong, Wanjie Huang, Jianhua Fu, Xindong Xue · 2019 · BioMed Research International
97. A review of the auditory-gut-brain axis
    Amy S. Graham, Benneth Ben‐Azu, Marie‐Ève Tremblay, Peter Torre, Marjanne Senekal, Barbara Laughton, Andre J. W. van der Kouwe, Marcin Jankiewicz, Mamadou Kaba, M. Holmes · 2023 · Frontiers in Neuroscience
98. α‐Synuclein Oligomers: A Study in Diversity
    Femke van Diggelen, Armand W.J.W. Tepper, Mihaela M. Apetri, Daniel E. Otzen · 2016 · Israel Journal of Chemistry
99. Intracerebroventricular injection of Aβ1-42 combined with two-vessel occlusion accelerate Alzheimer’s disease development in rats
    Shi Jie Dai, Jie Ying Zhang, Yu Ting Bao, Xiao Jie Zhou, Lu Ning Lin, Yun Bo Fu, Yu Jia Zhang, Changyu Li, Yuanxiao Yang · 2018 · Pathology - Research and Practice
100. GSK3β Impairs KIF1A Transport in a Cellular Model of Alzheimer’s Disease but Does Not Regulate Motor Motility at S402
     Kathlyn J. Gan, A. Akram, Teresa Lynne Blasius, Elisa M. Ramser, Breane G. Budaitis, Dominik R. Gabrych, Kristen J. Verhey, M.A. Silverman · 2020 · eNeuro